2022 Volume 62 Issue 7 Pages 1033-1037
Background. Antiretroviral therapy has been introduced to improve the prognosis of patients with human immunodeficiency virus (HIV) infection, and as a result, non-AIDS-defining cancer (NADC) may affect the prognosis. It has been shown that lung cancer patients with HIV progress faster in comparison to patients without HIV, and have a poor prognosis; however, there is no specific treatment protocol for lung cancer in patients with HIV. Case. The patient was a 55-year-old man who was diagnosed with advanced lung adenocarcinoma and infected with HIV. Platinum-based chemotherapy was administered, but the effect was poor, and docetaxel was started as the next treatment. He then showed prolonged myelosuppression, and his general condition worsened, making it difficult to continue chemotherapy. Conclusion. We report a case of advanced lung cancer in a patient with HIV infection. It is hoped that standard chemotherapy for advanced lung cancer with HIV infection will be established.
